跳至主要内容
临床试验/IRCT20121224011862N5
IRCT20121224011862N5招募中3 期

Effects of pravastatin on the prevention of preeclampsia in high-risk pregnant women: arandomized controlled clinical trial

Vice chancellor for Research,Tabriz0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Pregnant women at high risk for the possibility of preeclampsia
  • Consent to participate in the study
  • Pregnancy age 16 to 20 weeks
  • Having minimum literacy
  • Having a phone number to follow up
  • History of preeclampsia in previous pregnancy
  • In Vitro Fertilization (IVF)
  • Family history of preeclampsia
  • BMI 35 and above
  • Age over 40 years

排除标准

  • Uso de anticoagulantes, excepto aspirina.
  • History of allergy to statins
  • Multiple pregnancy
  • History of thrombophilia
  • Chronic kidney disease
  • Autoimmune disease
  • Cardiovascular diseases
  • Smoking and alcohol consumption

研究者

发起方
Vice chancellor for Research,Tabriz

相似试验